All lobbying filings

STUMPTOWN STRATEGIES

STUMPTOWN STRATEGIES filed a Q4 report for PRIME THERAPEUTICS on January 19, 2026, reporting $20,000 in lobbying income.

Lobbying for PRIME THERAPEUTICS · Healthcare

All filings by STUMPTOWN STRATEGIES · Everything PRIME THERAPEUTICS has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Minnesota

Official filing document

Lobbyists on this filing 1

BLAIR LARKINS

Previously held: Staff Assistant, Greg Walden 2005-2006, Executive Assistant, Greg Walden 2006-2001

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

PBM issues - Transparency, Delinking HR 2214 Drug Act

Pharmacy

HR 2214 DRUG Act Delinking, PBM Issues

Bills named in this filing 1

H.R. 2214
DRUG Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.